T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF
TMED
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1307 Point Street Baltimore MD United States of America 21231
- IPO Date
- Jun 12, 2025
- CIK
- 0001795351
- Similar Companies
- Business
- T. Rowe Price Exchange-Traded Funds, Inc. is an open-end management investment company that sponsors the T. Rowe Price Health Care ETF, an actively managed, transparent exchange-traded fund traded on The Nasdaq Stock Market LLC under the ticker TMED. Launched on June 11, 2025, TMED seeks long-term capital appreciation by investing principally in equity securities of health care companies, normally committing at least 80% of net assets, plus borrowings for investment purposes, to companies engaged in health care innovation. Its investment universe encompasses biotechnology companies; pharmaceutical manufacturers; life-sciences tools and services providers; diagnostic businesses; medical-products, medical-supplies and medical-device manufacturers; and health care services companies. The portfolio generally holds approximately 100 to 150 securities and is co-managed by Sal Rais, with biotechnology research coverage, and Jon Wood, with life-sciences, diagnostic-tools, medical-supplies and medical-devices coverage. The fund is nondiversified and offers investors exchange-traded exposure to the health care sector; its shares are bought and sold on Nasdaq and are not individually redeemable. TMED carries a 0.44% expense ratio and is distributed through financial intermediaries and other investment channels. T. Rowe Price Exchange-Traded Funds, Inc. is associated with T. Rowe Price Associates, Inc., a Baltimore, Maryland-based investment manager founded in 1937, and forms part of T. Rowe Price Group, Inc.’s global active-investment-management platform. The company’s latest major development was the June 2025 launch of TMED alongside the T. Rowe Price Financials ETF and T. Rowe Price Natural Resources ETF, expanding T. Rowe Price’s active transparent ETF lineup to 22 offerings and extending its sector-specific ETF capabilities.